首页 | 本学科首页   官方微博 | 高级检索  
     

逐瘀通脉胶囊联合长春西汀治疗慢性脑供血不足的临床研究
引用本文:刘国荣,王大力,张文丽,安亚臣,郑德松,姚林. 逐瘀通脉胶囊联合长春西汀治疗慢性脑供血不足的临床研究[J]. 天津中医药大学学报, 2012, 29(1): 22-25
作者姓名:刘国荣  王大力  张文丽  安亚臣  郑德松  姚林
作者单位:河北联合大学公共卫生学院, 唐山 063000;河北联合大学附属医院神经内二病区, 唐山 063000;河北联合大学医学实验研究中心, 唐山 063000;河北联合大学附属医院神经内二病区, 唐山 063000;河北联合大学附属医院神经内二病区, 唐山 063000;河北联合大学公共卫生学院, 唐山 063000
基金项目:唐山市科技局资助项目(10150204A-26)
摘    要:[目的]观察逐瘀通脉胶囊联合长春西汀注射液治疗慢性脑供血不足的临床疗效。[方法]将180例慢性脑供血不足患者随机分为4组,常规用药(抗血小板、营养神经,脑细胞活化剂)组41例,简称A组。口服逐瘀通脉胶囊加常规组43例,简称B组。静脉输入长春西汀注射液加常规组45例,简称C组。逐瘀通脉胶囊联合长春西汀注射液加常规组51例,简称D组,剂量同以上3组。观察比较各组临床疗效。[结果]D组总有效率为88.24%,高于A组(60.97%)、B组(72.09%)和C组(77.78%),差异有统计学意义(P<0.05),D组治疗后血脂、高敏C反应蛋白(hs-CRP)、血黏度、血液流速较治疗前明显改善(P<0.05),且优于B组和C组(P<0.05)。[结论]逐瘀通脉胶囊联合长春西汀注射治疗慢性脑供血不足,能更好地改善症状和脑血流速度,调节血脂、高敏C反应蛋白(hs-CRP)疗效优于常规用药、单纯使用逐瘀通脉胶囊或长春西汀。

关 键 词:逐瘀通脉胶囊  长春西汀注射液  临床疗效  慢性脑供血不足
收稿时间:2011-11-09

Clinical study on Zhuyu Tongmai capsules combined with Vinpocetine injection in treating chronic cerebral circulation insufficiency
LIU Guo-rong,WANG Da-li,ZHANG Wen-li,AN Ya-chen,ZHENG De-song and YAO Lin. Clinical study on Zhuyu Tongmai capsules combined with Vinpocetine injection in treating chronic cerebral circulation insufficiency[J]. Journal of Tianjin University of Traditonal Chinese Medicine, 2012, 29(1): 22-25
Authors:LIU Guo-rong  WANG Da-li  ZHANG Wen-li  AN Ya-chen  ZHENG De-song  YAO Lin
Affiliation:The School of Public Health, HeBei United University, Hebei 063000, China;The Second Disease District of Neurology, Affiliated Hospital of HeBei United University, Hebei 063000, China;Medical Experimental Center of HeBei United University, Hebei 063000, China;The Second Disease District of Neurology, Affiliated Hospital of HeBei United University, Hebei 063000, China;The Second Disease District of Neurology, Affiliated Hospital of HeBei United University, Hebei 063000, China;The School of Public Health, HeBei United University, Hebei 063000, China
Abstract:[Objective] To observe the clinical effect of Zhuyu Tongmai capsules combined with Vinpocetine injection in treating chronic cerebral circulation insufficiency.[Methods] 104 cases with chronic cerebral circulation insufficiency were randomly divided into four groups: group A,41 cases,were treated with normal medicine;group B,43 cases,treated with normal medicine and Zhuyu Tongmai capsules;group C,45 cases,treated with normal medicine and Vinpocetine injection;group D,51 cases,treated with normal medicine and Zhuyu Tongmai capsules combined with Vinpocetine injection.The clinical effects of the four groups were then compared.[Results] The total effective rate was 96.07% in patients with group D,its curative effect was significantly higher than those in group A(60.97%),B(72.09%) and C(73.33%) with statistical significance(P<0.05).The blood fat.high-sensitive C-reactive protein(hs-CRP),the whole blood viscosity and blood flow speed in group D after treatment were improved significantly when compared with pre-treatment(P<0.05),and the effect was superior than Zhuyu Tongmai capsules group or Vinpocetine injection group(P<0.05).[Conclusion] The normal medicine and Zhuyu Tongmai capsules combined with Vinpocetine injection can improve effectively the blood fat,high-sensitive C-reactive protein(hs-CRP),the whole blood viscosity and blood flow speed in patients with chronic cerebral circulation insufficiency,its effect is better than that treated only with normal medicine,Zhuyu Tongmai capsules or Vinpocetine injection.
Keywords:Zhuyu Tongmai capsules  Vinpocetine injection  clinical study  chronic cerebral circulation insufficiency
点击此处可从《天津中医药大学学报》浏览原始摘要信息
点击此处可从《天津中医药大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号